TAG: "solarising pharma sector"

News

AMPIN Energy Transition Signs PPA with Poly Medicure to Supply 9.9 MWp Solar Power in Haryana

AMPIN Energy Transition has signed a 9.9 MWp solar power PPA with Poly Medicure, supporting the company's sustainability goals by supplying solar energy to five plants in Faridabad from its 75 MWp solar park in Sirsa, Haryana.

Solarising Pharma Sector | April 03, 2025 | By Mrinmoy Dey | 598

Shree Ganesh Remedies Commissions 2 MW Captive Solar Plant in Gujarat

Gujarat-based pharmaceutical company Shree Ganesh Remedies Ltd. has commissioned a 2 MW solar power plant in Gujarat, covering 70 percent of its power needs. The project is expected to generate annual savings of approximately INR 2 crore in electricity expenses.

Solarising Pharma Sector | March 26, 2025 | By Mrinmoy Dey | 316

Syngene International to Procure Wind-Solar Hybrid Power from O2 Power in Karnataka

Syngene International Ltd., a Bengaluru-based pharmaceutical company, will procure renewable energy from O2 Power’s 201.2 MW wind-solar hybrid plant in Karnataka under a captive arrangement. The company acquired 33.79 percent stake in the SPV for INR 6.5 crore.

Solarising Pharma Sector | March 25, 2025 | By Mrinmoy Dey | 417

Aurobindo Pharma to Procure 30 MW AC Solar Power from Swarnaaskshu

Hyderabad-based Aurobindo Pharma has signed a power purchase agreement with Swarnaaskshu Solar Power to procure solar energy under a captive arrangement. It will be investing up to INR 10.40 crore for a 26 percent stake in the company's planned 30 MW AC (40 MW DC) solar plant in Telangana.

Solarising Pharma Sector | February 07, 2025 | By Mrinmoy Dey | 749

Aarti Drugs to Procure 24.40 MWp Solar Power from Prozeal Green Energy

Aarti Drugs has partnered with Prozeal Green Energy to procure solar power through a captive arrangement, acquiring a 26.25 percent stake in an SPV for INR 8.05 crore to develop a 24.40 MWp solar power plant.

Solarising Pharma Sector | February 04, 2025 | By Mrinmoy Dey | 705

Concord Biotech to Procure 9.9 MW Wind-Solar Hybrid Power from CleanMax

Ahmedabad-based pharmaceutical company Concord Biotech will procure 9.9 MW wind-solar hybrid power through a captive arrangement with Clean Max Enviro Energy Solutions (CleanMax), marking its first investment in renewable energy to power its manufacturing plant at Dholka in Gujarat.

Solarising Pharma Sector | January 18, 2025 | By Mrinmoy Dey | 897